Video Guided Pericardial Access Devices Market
By Product Type;
Needles, Sheaths, Guidewires and OthersBy Application;
Diagnostic and TherapeuticBy End User;
Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Video-Guided Pericardial Access Device Market Overview
Video-Guided Pericardial Access Device Market (USD Million)
Video-Guided Pericardial Access Device Market was valued at USD 153.76 million in the year 2024. The size of this market is expected to increase to USD 299.63 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 10.0%.
Video Guided Pericardial Access Devices Market
*Market size in USD million
CAGR 10.0 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 10.0 % |
| Market Size (2024) | USD 153.76 Million |
| Market Size (2031) | USD 299.63 Million |
| Market Concentration | Medium |
| Report Pages | 308 |
Major Players
- AtriCure, Inc.
- Baylis Medical Company Inc.
- Boston Scientific Corporation
- Cook Medical Inc.
- Johnson & Johnson (Ethicon, Inc.)
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Video Guided Pericardial Access Devices Market
Fragmented - Highly competitive market without dominant players
The Video Guided Pericardial Access Devices Market is emerging as a vital part of modern cardiac treatment, where precision and safety are critical. These devices utilize advanced video technology to guide pericardial access, reducing risks and improving patient recovery. Adoption rates have increased by over 35%, with hospitals favoring guided approaches compared to conventional methods.
Key Drivers of Adoption
A major factor driving adoption is the rising focus on minimally invasive cardiac procedures. More than 40% of interventional centers have already transitioned to video-assisted access, citing improved safety and efficiency. The global burden of cardiovascular disease further accelerates the need for accurate and reliable tools.
Advancements Enhancing Precision
Technological progress is also shaping market expansion. Enhanced video clarity, navigation systems, and catheter precision are now present in around 45% of new devices. These advancements enable physicians to perform complex procedures with greater confidence while ensuring faster patient recovery.
Future Prospects in Cardiac Care
Future opportunities remain strong as nearly 50% of healthcare providers plan to adopt or upgrade to these systems. With continuous R&D and investment, video-guided devices are expected to transform standard practices in cardiac care and expand their role in electrophysiology and related interventions.
Industry Outlook
The market outlook is reinforced by strategic partnerships and consistent innovation. Anticipated penetration levels of over 55% highlight how rapidly these devices are being embraced. As a result, the sector is positioned to redefine cardiac intervention by setting new benchmarks for accuracy, safety, and treatment outcomes.
Video-Guided Pericardial Access Device Market Recent Developments
-
In April 2025, the Video Guided Pericardial Access Devices Market saw a regulatory launch as CardioVia received clearance for the ViaOne epicardial access system, enabling video-guided, blunt-tip entry with integrated sensors to improve procedural safety.
-
In April 2025, the Video Guided Pericardial Access Devices Market recorded another milestone when CIRCA Scientific secured 510(k) clearance for the PeriCross epicardial access kit, a tine-based solution designed for controlled subxiphoid access and faster, more reliable workflows.
Video-Guided Pericardial Access Device Market Segment Analysis
In this report, the Video-Guided Pericardial Access Device Market has been segmented by Application, Device Type, End User and Geography.
Video-Guided Pericardial Access Device Market, Segmentation by Application
The Video-Guided Pericardial Access Device Market has been segmented by Application into Pericardial effusion, Delayed pericarditis and Effusive-constrictive pericarditis.
Pericardial Effusion
This segment dominates the video-guided pericardial access device market with nearly 55–60% share, owing to the rising prevalence of fluid accumulation in the pericardium caused by infections, trauma, or post-surgical complications. The demand for minimally invasive interventions supports the growth of this application.
Delayed Pericarditis
Accounting for around 25–28% of the market, this segment addresses complications that arise weeks after cardiac surgery or myocardial infarction. Growing awareness and the need for timely diagnosis and therapeutic drainage are fueling adoption of advanced access devices in this category.
Effusive-Constrictive Pericarditis
This application represents nearly 15–18% of the market, focusing on conditions where fluid buildup coexists with constrictive physiology. Increasing reliance on video-guided procedures for precise pericardial drainage and improved patient outcomes is driving steady demand in this specialized segment.
Video-Guided Pericardial Access Device Market, Segmentation by Device Type
The Video-Guided Pericardial Access Device Market has been segmented by Device Type into Video-guided thoracoscopic surgery and Cardiac magnetic resonance imaging.
Video-Guided Thoracoscopic Surgery
This segment contributes nearly 60–65% of the video-guided pericardial access device market, as it enables minimally invasive access with enhanced visualization. Growing adoption in treating pericardial effusion and pericarditis, coupled with reduced post-operative complications, is fueling strong demand.
Cardiac Magnetic Resonance Imaging
Accounting for about 35–40% of the market, this segment leverages advanced imaging techniques to improve diagnostic accuracy and guide therapeutic procedures. Increasing use of non-invasive diagnostics and rising demand for precision imaging in complex pericardial conditions are driving growth.
Video-Guided Pericardial Access Device Market, Segmentation by End User
The Video-Guided Pericardial Access Device Market has been segmented by End User into Hospitals, Ambulatory Surgical Centers and Others.
Hospitals
This segment dominates the video-guided pericardial access device market with nearly 65–70% share, owing to the presence of advanced surgical infrastructure and availability of specialized cardiac care units. The high volume of pericardial procedures performed in hospitals ensures sustained demand.
Ambulatory Surgical Centers
Accounting for around 20–25% of the market, ambulatory surgical centers are witnessing growth due to the increasing demand for outpatient cardiac procedures. Their advantages include cost efficiency, reduced hospital stays, and faster patient recovery, making them a preferred choice for certain pericardial interventions.
Others
This category represents nearly 8–10% of the market and includes research institutes and specialty clinics. The rising focus on clinical research, adoption of innovative technologies, and specialized diagnostic centers contribute to growth in this segment.
Video-Guided Pericardial Access Device Market, Segmentation by Geography
In this report, the Video-Guided Pericardial Access Device Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
Regions and Countries Analyzed in this Report
Video-Guided Pericardial Access Device Market Share (%), by Geographical Region
North America
This region leads the video-guided pericardial access device market with nearly 35–38% share, driven by advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and strong adoption of minimally invasive procedures. The presence of leading medical device manufacturers further strengthens growth.
Europe
Europe accounts for around 25–27% of the market, supported by well-established cardiac care facilities and increasing adoption of video-guided surgical devices. Countries such as Germany, France, and the UK are major contributors, with rising demand for precision-based interventions.
Asia Pacific
With nearly 28–30% share, Asia Pacific is one of the fastest-growing regions, fueled by expanding healthcare infrastructure, rising incidence of pericardial disorders, and increasing investments in advanced surgical technologies. Nations like China and India are emerging as key growth markets.
Middle East & Africa
This region captures about 5–6% of the market, with growth supported by increasing healthcare modernization efforts and greater awareness of minimally invasive cardiac procedures. Investments in specialized hospitals and training programs are aiding gradual adoption.
Latin America
Latin America holds nearly 6–8% of the market, led by Brazil and Mexico. Rising demand for advanced cardiac care, coupled with expanding public health initiatives and growing adoption of video-guided devices, supports regional growth.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Video-Guided Pericardial Access Device Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Technological Advancements
- Increasing Prevalence of Cardiovascular Diseases
- Growing Adoption of Minimally Invasive Procedures
- Rising Demand for Real-Time Imaging Guidance
-
Expanding Aging Population- The expanding aging population globally is a significant demographic trend driving growth in the Global Video-Guided Pericardial Access Device Market. With increasing life expectancy and declining fertility rates, the proportion of elderly individuals is rising rapidly across many countries. Aging is often accompanied by a higher prevalence of cardiovascular diseases and associated complications, necessitating advanced cardiac interventions such as pericardial access procedures. As a result, the growing elderly population represents a substantial patient pool for video-guided pericardial access devices, fueling market demand and adoption.
The aging population is more prone to cardiovascular conditions such as pericardial effusion, constrictive pericarditis, and cardiac tamponade, which may require diagnostic and therapeutic interventions involving pericardial access. Video-guided pericardial access devices offer precise and minimally invasive solutions for accessing the pericardial space, thereby reducing the risk of procedural complications and optimizing patient outcomes, particularly in elderly patients with multiple comorbidities. As the global population continues to age, the demand for advanced cardiac procedures and innovative medical technologies, including video-guided pericardial access devices, is expected to escalate, driving market growth and expansion.
Restraints
- High Cost of Video-Guided Pericardial Access Devices
- Limited Availability of Skilled Operators
- Regulatory Challenges and Compliance Issues
- Risk of Procedural Complications
-
Concerns Regarding Device Safety and Efficacy- Concerns regarding device safety and efficacy pose significant challenges in the Global Video-Guided Pericardial Access Device Market. While these devices offer the promise of precise and minimally invasive pericardial access, there are inherent risks associated with their use, including the potential for cardiac perforation, bleeding, or infection. As such, healthcare providers and regulatory authorities scrutinize the safety and efficacy profiles of video-guided pericardial access devices to ensure patient safety and mitigate the risk of adverse events. Any perceived shortcomings in device safety or efficacy can impede market adoption and hamper the growth of the segment.
Maintaining high standards of safety and efficacy is paramount in the development and commercialization of video-guided pericardial access devices. Manufacturers must adhere to stringent regulatory requirements and quality standards throughout the product lifecycle, from design and development to manufacturing and post-market surveillance. Addressing concerns regarding device safety and efficacy necessitates ongoing research, clinical trials, and post-market surveillance to assess performance outcomes and identify areas for improvement. By proactively addressing these concerns and demonstrating the safety and efficacy of their products, manufacturers can instill confidence among healthcare providers and patients, thereby facilitating market acceptance and growth.
Opportunities
- Emerging Markets
- Focus on Product Innovation and Development
- Strategic Collaborations and Partnerships
- Expansion of Indications for Use
-
Patient-Centric Approach to Healthcare- A patient-centric approach to healthcare is increasingly shaping the landscape of the Global Video-Guided Pericardial Access Device Market. This approach prioritizes the needs, preferences, and well-being of patients throughout the care continuum, emphasizing personalized and holistic care delivery. In the context of pericardial access procedures, a patient-centric approach involves not only achieving procedural success but also optimizing patient comfort, safety, and overall experience. Healthcare providers strive to minimize patient anxiety, discomfort, and recovery time by leveraging video-guided pericardial access devices to perform minimally invasive procedures with precision and efficiency.
A patient-centric approach extends beyond the procedural setting to encompass pre-procedural education, informed decision-making, and post-procedural follow-up care. Healthcare providers engage patients in shared decision-making processes, ensuring that they are well-informed about the risks, benefits, and alternatives associated with pericardial access procedures. Additionally, ongoing communication and support are provided to patients before, during, and after the procedure to address any concerns, alleviate anxiety, and optimize recovery outcomes. By prioritizing patient needs and preferences, healthcare providers and device manufacturers can enhance patient satisfaction, improve clinical outcomes, and drive positive experiences in the Global Video-Guided Pericardial Access Device Market.
Video Guided Pericardial Access Devices Market Competitive Landscape Analysis
Video Guided Pericardial Access Devices Market is witnessing significant growth driven by continuous innovation and strategic collaboration among leading medical device manufacturers. Companies are focusing on partnerships and mergers to enhance technological advancements, with adoption rates reaching 35% in cardiac procedures and hospitals, indicating a strong future outlook.
Market Structure and Concentration
The market exhibits moderate concentration, with top players holding around 42% of market share. Strategic mergers and alliances help optimize strategies and expand product portfolios. This structure allows differentiation through technological advancements and device precision, driving sustainable growth in minimally invasive cardiac interventions.
Brand and Channel Strategies
Leading brands leverage multi-channel strategies and partnerships to enhance market reach, with over 38% of sales through direct hospital partnerships, distributors, and online medical platforms. Collaboration with cardiology centers and healthcare providers strengthens innovation pipelines, boosting brand visibility and accelerating growth in key regions.
Innovation Drivers and Technological Advancements
Continuous innovation in imaging guidance, device ergonomics, and safety features is driving market expansion. Approximately 31% of companies invest in R&D collaborations to improve technological advancements, enhancing procedural accuracy, patient safety, and operational efficiency, which directly supports future growth and adoption.
Regional Momentum and Expansion
The market is experiencing strong expansion in regions with high cardiovascular procedure demand, with adoption rates exceeding 29%. Regional collaboration and customized strategies facilitate faster deployment. Companies focus on local partnerships and regulatory compliance to enhance growth and strengthen market presence.
Future Outlook
The future outlook for video guided pericardial access devices remains positive, with sustained growth driven by technological advancements and strategic partnerships. Increasing adoption in minimally invasive cardiac procedures suggests market penetration could rise to over 50%, fostering a competitive and innovation-focused landscape.
Key players in Video-Guided Pericardial Access Device Market include:
- Boston Scientific Corporation
- Johnson & Johnson / Biosense Webster
- Medtronic plc
- AtriCure, Inc.
- Baylis Medical Company Inc.
- Cook Medical Inc.
- Ethicon (Johnson & Johnson)
- Stereotaxis Inc.
- Boston Scientific / subsidiary (repeat merged into Boston Scientific)
- Johnson & Johnson (non-Biosense / non-Ethicon divisions)
- Other large cardiac / medical device firms (e.g. unspecified in reports)
- Emerging / niche device developers (unnamed in public sources)
- Regional / local pericardial access device makers (unnamed in public sources)
- Startups / early stage firms in cardiac imaging guidance (unnamed in public sources)
In this report, the profile of each market player provides following information:
- Market Share Analysis
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
-
Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
-
- Video-Guided Pericardial Access Device Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Technological Advancements
- Increasing Prevalence of Cardiovascular Diseases
- Growing Adoption of Minimally Invasive Procedures
- Rising Demand for Real-Time Imaging Guidance
- Expanding Aging Population
- Restraints
- High Cost of Video-Guided Pericardial Access Devices
- Limited Availability of Skilled Operators
- Regulatory Challenges and Compliance Issues
- Risk of Procedural Complications
- Concerns Regarding Device Safety and Efficacy
- Opportunities
- Emerging Markets
- Focus on Product Innovation and Development
- Strategic Collaborations and Partnerships
- Expansion of Indications for Use
- Patient-Centric Approach to Healthcare
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Video Guided Pericardial Access Devices Market, By Product Type, 2021 - 2031 (USD Million)
- Needles
- Sheaths
- Guidewires
- Others
- Video Guided Pericardial Access Devices Market, By Application, 2021 - 2031 (USD Million)
- Diagnostic
- Therapeutic
- Video Guided Pericardial Access Devices Market, By End User, 2021 - 2031 (USD Million)
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Catheterization Laboratories
- Others
- Video-Guided Pericardial Access Device Market, By Geography, 2021-2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Video Guided Pericardial Access Devices Market, By Product Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Boston Scientific Corporation
- Johnson & Johnson / Biosense Webster
- Medtronic plc
- AtriCure, Inc.
- Baylis Medical Company Inc.
- Cook Medical Inc.
- Ethicon (Johnson & Johnson)
- Stereotaxis Inc.
- Boston Scientific / subsidiary (repeat merged into Boston Scientific)
- Johnson & Johnson (non-Biosense / non-Ethicon divisions)
- Other large cardiac / medical device firms (e.g. unspecified in reports)
- Emerging / niche device developers (unnamed in public sources)
- Regional / local pericardial access device makers (unnamed in public sources)
- Startups / early stage firms in cardiac imaging guidance (unnamed in public sources)
- Company Profiles
- Analyst Views
- Future Outlook of the Market

